ANRO: Alto Neuroscience Inc.
Performance
ANRO +140.69%
Watchlist
Select an item
Summary
ANRO at a glance
ANRO returned +140.69% over the past year. Its worst drop in that year was -40.75%, smaller than 36% of stocks on Redstone, and its Sharpe ratio of 1.47 beats 91% of stocks on Redstone. It pays no dividends.
Current Drawdown
-24.13%
Rolling Volatility
86.79%
Actions
Metrics
Risk Indicators
Alpha97.22%
Beta1.77x
Sharpe1.47
Sortino2.32
Omega1.29
Calmar3.45
Martin6.40
Profile
About ANRO
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $1.1B
- Listed
- Feb 2024
- Employees
- 68
- Headquarters
- Mountain View, CA
- Website
- altoneuroscience.com
Comparisons